Monday, January 19, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Needham Analyst Reiterates Buy Rating and 28 Price Target for Liquidia Technologies

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Biotechnology Trading online
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Needham analyst Serge Belanger has reiterated his Buy rating and $28 price target for Liquidia (NASDAQ:LQDA) on March 13, 2024. This reaffirmation underscores his optimistic view on the company’s future performance and growth opportunities. Belanger’s analysis is in line with the overall market sentiment, showcasing a strong belief in Liquidia Technologies amid favorable market conditions and regulatory environment. The ongoing endorsement from Needham signifies a continued confidence in the company’s potential, as echoed by various analyst perspectives.

LQDA Stock Shows Strong Performance with 5.36% Increase on March 13, 2024

On March 13, 2024, LQDA stock showed strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of LQDA shares increased by $0.75 since the market last closed, representing a 5.36% rise. The stock closed at $14.73, showing a significant increase in value. Additionally, in after-hours trading, the stock rose by an additional $0.21. Investors and analysts may view these price movements as a sign of strength in the stock, as it continues to show growth and potential for further gains. It is important for investors to conduct thorough research and analysis before making any investment decisions.

LQDA Stock Analysis: Revenue Flat, Net Income Improves – March 13, 2024

On March 13, 2024, LQDA stock had a mixed performance based on the financial data provided by CNN Money. The total revenue for LQDA stood at $15.94 million for the past year, which remained flat compared to the previous year. However, there was a significant decrease of 23.15% in total revenue since the last quarter, with the company reporting $3.68 million in revenue for Q3.

The net income for LQDA was reported at -$41.02 million for the past year, showing a decrease of 18.61% compared to the previous year. However, there was a positive sign as the net income improved by 32.86% since the last quarter, with a reported net income of -$15.79 million for Q3.

Earnings per share (EPS) for LQDA were reported at -$0.67 for the past year, showing a slight increase of 3.35% compared to the previous year. The EPS also saw a significant improvement of 32.92% since the last quarter, with a reported EPS of -$0.24 for Q3.

Tags: LQDA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biopharmaceutical Stock Market Today (1)

Title Poseida Therapeutics Receives Orphan Drug Designation for PBCMAALLO1 Targeting Multiple Myeloma

From Stress Relief to Sleep Improvement: Unveiling the Latest Innovations in Vagus Nerve Stimulation Devices

Cue Health NASDAQ HLTH Q4 Earnings Report Key Highlights

Automotive Trading online

Vroom Inc Q4 Financial Results Impact Stock Performance and Future Outlook

Recommended

Ocugen Stock

Ocugen Shares Retreat Despite Upbeat Pipeline Updates

4 months ago
Industrial Metals and Mining stock Trading

Anticipating Alliance Resource Partners Quarterly Earnings Report and Market Impact

2 years ago
Plug Power Stock

Plug Power Stock: Mixed Q2 Results Spark Uncertainty

5 months ago
Ethereum Stock

Ethereum’s Quiet Phase Masks Underlying Turmoil

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

A New Buy Rating Sparks Interest in Quantum Computing Firm Rigetti

Fannie Mae Shares Plunge on New Government Mortgage Mandate

A Landmark Discovery for Max Power Mining

Legal Challenges Mount for DeFi Technologies Stock

Micron’s Strategic Acquisition to Accelerate Memory Production

Netflix Shares Face Critical Test Amid Acquisition Uncertainty

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: M&A Speculation Heats Up in Weight-Loss Drug Race

by Robert Sasse
January 19, 2026
0

Shares of Viking Therapeutics have posted significant gains, fueled by renewed takeover speculation within the obesity drug...

ImmunityBio Stock

ImmunityBio Shares Surge on Clinical and Commercial Milestones

January 19, 2026
Arafura Stock

Arafura Resources Nears Critical Funding Milestone for Flagship Project

January 19, 2026
Rigetti Stock

A New Buy Rating Sparks Interest in Quantum Computing Firm Rigetti

January 19, 2026
Fannie Mae Stock

Fannie Mae Shares Plunge on New Government Mortgage Mandate

January 19, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: M&A Speculation Heats Up in Weight-Loss Drug Race
  • ImmunityBio Shares Surge on Clinical and Commercial Milestones
  • Arafura Resources Nears Critical Funding Milestone for Flagship Project

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com